Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Khalil Barrage | M | 59 | - | |
| Vincent Serra | M | 55 | 5 years | |
| Cédric Moreau | M | 37 | - | |
| John Furey | M | 59 | 5 years | |
| Eric Forquenot de la Fortelle | M | - | 9 years | |
| Aniz Girach | M | 57 | 2 years | |
| Julien Miara | M | - | - | |
| Nawal Ouzren | F | 45 | 7 years | |
| Federico Mingozzi | M | 50 |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 5 years |
| Noémie Djokovic | F | - | - | |
| Florian Reinaud | M | 51 | - | |
| Géraldine Honnet | M | - | 4 years | |
| Judith Laredo | M | - | - | |
| Natalie Berner | F | 34 | - | |
| Bernd Schmidt | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Miguel Sieler | M | 74 | 6 years | |
| Patrick J. Langlois | M | 78 | 5 years | |
| Scott Myers | M | 57 | 2 years | |
| Edwin Moses | M | 69 | 1 years | |
| David Lawrence | M | 61 | - | |
| François Thomas | M | 66 |
Cytheris SA
 Cytheris SA Pharmaceuticals: MajorHealth Technology Cytheris SA develops and manufactures drugs for immune modulation. It is a clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases. The firm's product CYT107 (glycosylated r-hIL-7), is in clinical development for two targeted indications with urgent medical needs and no current treatments: Progressive Multifocal Leukoencephalopathy (PML) in severely lymphopenic patients and Reduction of complications in Immune Non-Responders with HIV controlled by anti-retroviral treatment (HIV-INR). Cytheris has locations in France and The United States. The company was founded in January 1999 by Michel Morre and is headquartered in Issy-les-Moulineaux, France. | 1 years |
| Géraldine Grouard-Vogel | M | - | 14 years | |
| Thérèse Croughs | M | - | 4 years | |
| Jean-François Morin | M | - | - | |
| Fulvio Mavilio | M | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 5 years |
| Etienne Daher | M | - | 2 years | |
| Nora Yang | M | - | - | |
| Otmane Boussif | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| France | 28 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Valerie Salentey
- Personal Network